Your browser doesn't support javascript.
loading
Arenobufagin-loaded PEG-PLA nanoparticles for reducing toxicity and enhancing cancer therapy.
Jiaying, Yang; Bo, Sun; Xiaolu, Wei; Yanyan, Zhou; Hongjie, Wang; Nan, Si; Bo, Gao; Linna, Wang; Yan, Zhang; Wenya, Gao; Keke, Luo; Shan, Jiang; Chuan, Luo; Yu, Zhao; Qinghe, Zhao; Haiyu, Zhao.
Afiliación
  • Jiaying Y; China Academy of Chinese Medical Sciences, Institute of Chinese Materia Medica, Beijing, China.
  • Bo S; China Academy of Chinese Medical Sciences, Institute of Chinese Materia Medica, Beijing, China.
  • Xiaolu W; China Academy of Chinese Medical Sciences, Institute of Chinese Materia Medica, Beijing, China.
  • Yanyan Z; China Academy of Chinese Medical Sciences, Institute of Chinese Materia Medica, Beijing, China.
  • Hongjie W; China Academy of Chinese Medical Sciences, Institute of Chinese Materia Medica, Beijing, China.
  • Nan S; China Academy of Chinese Medical Sciences, Institute of Chinese Materia Medica, Beijing, China.
  • Bo G; China Resources Sanjiu Modern Traditional Chinese Medicine Pharmaceutical Co., Ltd, Shenzhen, China.
  • Linna W; China Academy of Chinese Medical Sciences, Institute of Chinese Materia Medica, Beijing, China.
  • Yan Z; China Academy of Chinese Medical Sciences, Institute of Chinese Materia Medica, Beijing, China.
  • Wenya G; China Academy of Chinese Medical Sciences, Institute of Chinese Materia Medica, Beijing, China.
  • Keke L; China Academy of Chinese Medical Sciences, Institute of Chinese Materia Medica, Beijing, China.
  • Shan J; China Academy of Chinese Medical Sciences, Institute of Chinese Materia Medica, Beijing, China.
  • Chuan L; Anhui Huarun Jinchan Pharmaceutical Co., Ltd, Anhui, China.
  • Yu Z; China Academy of Chinese Medical Sciences, Institute of Chinese Materia Medica, Beijing, China.
  • Qinghe Z; China Academy of Chinese Medical Sciences, Institute of Chinese Materia Medica, Beijing, China.
  • Haiyu Z; China Academy of Chinese Medical Sciences, Institute of Chinese Materia Medica, Beijing, China.
Drug Deliv ; 30(1): 2177362, 2023 Dec.
Article en En | MEDLINE | ID: mdl-36772846
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nanopartículas / Neoplasias Límite: Animals Idioma: En Revista: Drug Deliv Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nanopartículas / Neoplasias Límite: Animals Idioma: En Revista: Drug Deliv Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido